Although the role of TP53 on neuroblastoma tumorigenesis is still under debate, our preliminary findings prompted us to investigate the association between the highly prevalent p.R337H mutation and pediatric neuroblastoma. This evidence concerns the gene TP53 and neuroblastoma.